Cancer Center | Nicklaus Children's Hospital

Leukemia and Lymphoma Program

Our pediatric Leukemia and Lymphoma Program provides care for children with malignancies. Using the latest advances in treatment for leukemia in children, the majority of our patients with leukemia and lymphoma reach adulthood. The Cancer and Blood Disorders Center at Nicklaus Children's Hospital is nationally recognized and provides highly specialized and sophisticated treatment for pediatric leukemia patients – always with a focus on the best long-term results and minimization of possible late side effects.

Leukemia remains the most common childhood malignancy, with approximately 5,000 new cases of leukemia in children diagnosed annually in the United States, accounting for 30 percent of childhood cancers.

There are two common types of Leukemia that we treat at Nicklaus Children’s:

  • Acute lymphoblastic leukemia (ALL) is the type of leukemia that most commonly affects children, accounting for around 70 percent of leukemia cases each year in the U.S.
  • Acute myelogenous leukemia (AML) is the second most common form of leukemia in children. AML generally occurs by the age of 2, and is not often seen in older children until the teenage years. AML is the most common type of acute leukemia in adults. 

The chronic forms of leukemia such as chronic myelogenous leukemia (CML) are rarely seen in children.

This page was last updated on: 11/28/2018 9:07:23 AM

Contact the Cancer Center

Meet our July Patient of the Month, Lacy. Lacy was only 2 years old when her parents noticed that something was wrong. They took her to various doctors to try to find what could be the cause, Lacy had an 8 cm. tumor in her brain, occupying most of the lower part of her head.

Service Locations

Nicklaus Children's Hospital Main Campus
3100 SW 62nd Avenue
Miami, FL 33155

Children's Oncology Group

Designated as a Blue Distinction Center for Transplants


Recognized by the American College of Surgeons Commission on Cancer


Accredited by the Foundation for the Accrediation of Cellular Therapies (FACT)


Partnered with the Tyler Robinson Foundation.